← Back to search

MEDPACE HOLDINGS, INC.

MEDP · NASDAQ

Research and Development in Biotechnology

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace's mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 3,400 people across 37 countries.

ESG Scores

Overall ESG
3.8
Environmental
7.1
Social
4.7
Governance
4.6

Gender Diversity

Female Directors0.16670000000000001%
Female Executives0.12396694214876033%
Women in Workforce0.67%
CEO GenderMale

Market Data

Price$524.49+3.89 (+0.75%)
Market Cap$14.87B
P/E Ratio32.96
EPS$—
52W High$628.92
52W Low$250.05
Beta1.37